PharmAla Biotech Holdings, Inc.'s total assets for Q3 2025 were C$3.63M, a decrease of -7.03% from the previous quarter. TSE:MDMA total liabilities were C$876.15K for the fiscal quarter, a 7.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.